Genetic variants of PKLR are associated with acute pain in sickle cell disease X Wang, K Gardner, MB Tegegn, CL Dalgard, C Alba, S Menzel, H Patel, ... Blood advances 6 (11), 3535-3540, 2022 | 11 | 2022 |
Under-reporting and under-representation of non-Hispanic Black subjects in lipid-lowering atherosclerotic cardiovascular disease outcomes trials: A systematic review JK Grant, M Dangl, M Koester, M Tegegn, L Knijnik, H Singh, CE Orringer Journal of clinical lipidology 16 (5), 608-616, 2022 | 5 | 2022 |
Pklr variants associated with acute pain in sickle cell disease influence ATP concentrations in red blood cells X Wang, YP Fu, Q Li, EB Dunkelberger, M Tegegn, PA Kosinski, ... Blood 140 (Supplement 1), 954-956, 2022 | 1 | 2022 |
Random forest classifiers trained on simulated data enable accurate short read-based genotyping of structural variants in the alpha globin region at Chr16p13. 3 NF Hansen, X Wang, MB Tegegn, Z Liu, MH Gouveia, G Hill, JC Lin, ... bioRxiv, 2023 | | 2023 |
NON-HISPANIC BLACK AND AFRICAN AMERICAN (NHB/AA) PATIENTS: UNDERREPORTED AND UNDERREPRESENTED IN RANDOMIZED CONTROLLED TRIALS OF LIPID LOWERING THERAPY JK Grant, M Dangl, M Koester, M Tegegn, LM Knijnik, H Singh, ... Journal of the American College of Cardiology 79 (9_Supplement), 1647-1647, 2022 | | 2022 |
Pklr Is a Genetic Modifier of Sickle Cell Disease X Wang, M Tegegn, F Seifuddin, S Menzel, H Patel, YP Fu, N Jeffries, ... Blood 138, 953, 2021 | | 2021 |